Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Revenue (2020 - 2025)

RxSight's Revenue history spans 6 years, with the latest figure at $32.6 million for Q4 2025.

  • For Q4 2025, Revenue fell 18.91% year-over-year to $32.6 million; the TTM value through Dec 2025 reached $134.5 million, down 3.89%, while the annual FY2025 figure was $134.5 million, 3.89% down from the prior year.
  • Revenue reached $32.6 million in Q4 2025 per RXST's latest filing, up from $30.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $40.2 million in Q4 2024 to a low of $3.5 million in Q1 2021.
  • Average Revenue over 5 years is $21.8 million, with a median of $21.5 million recorded in 2023.
  • Peak YoY movement for Revenue: skyrocketed 189.46% in 2021, then fell 18.91% in 2025.
  • A 5-year view of Revenue shows it stood at $8.4 million in 2021, then skyrocketed by 90.93% to $16.1 million in 2022, then skyrocketed by 77.65% to $28.6 million in 2023, then soared by 40.71% to $40.2 million in 2024, then dropped by 18.91% to $32.6 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Revenue are $32.6 million (Q4 2025), $30.3 million (Q3 2025), and $33.6 million (Q2 2025).